Measurement of liver function using hepatobiliary scintigraphy improves risk assessment in patients undergoing major liver resection

HPB

Volumn 18, Issue 9, 2016, Pages 773-780

  Cieslak, Kasia P ^a   Bennink, Roelof J ^a   de Graaf, Wilmar ^b   van Lienden, Krijn P ^a   Besselink, Marc G ^a   Busch, Olivier R C ^a   Gouma, Dirk J ^a   van Gulik, Thomas M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBROFENIN TC 99M; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; IMINO ACID; MEBROFENIN TC 99M; TECHNETIUM COMPLEX;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLIZATION; BODY WEIGHT; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FUTURE REMNANT LIVER FUNCTION; HEPATOBILIARY SCINTISCANNING; HUMAN; LIVER FAILURE; LIVER FUNCTION; LIVER RESECTION; LIVER WEIGHT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PORTAL VEIN; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; RISK ASSESSMENT; STANDARDIZATION; SURGICAL RISK; TREATMENT INDICATION; COMPARATIVE STUDY; DIAGNOSTIC IMAGING; HEPATIC PORTAL VEIN; LIVER; LIVER FUNCTION TEST; MIDDLE AGED; ORGAN SIZE; PATHOPHYSIOLOGY; PREDICTIVE VALUE; RETROSPECTIVE STUDY; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY-COMPUTED TOMOGRAPHY; SURGERY; TREATMENT OUTCOME;

AGED; EMBOLIZATION, THERAPEUTIC; FEMALE; HEPATECTOMY; HUMANS; IMINO ACIDS; LIVER; LIVER FAILURE; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; ORGAN SIZE; ORGANOTECHNETIUM COMPOUNDS; PORTAL VEIN; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY COMPUTED TOMOGRAPHY; TREATMENT OUTCOME;

EID: 84979673421     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1016/j.hpb.2016.06.006     Document Type: Article

References (16)

1. 1 van den Broek, M.A., Olde Damink, S.W., Dejong, C.H., Lang, H., Malago, M., Jalan, R., et al. Liver failure after partial hepatic resection: definition, pathophysiology, risk factors and treatment. Liver Int 28 (2008), 767–780.
2. 2 Cieslak, K.P., Runge, J.H., Heger, M., Stoker, J., Bennink, R.J., van Gulik, T.M., New perspectives in the assessment of future remnant liver. Dig Surg 2014 31 (2014), 255–268.
3. 3 Truant, S., Oberlin, O., Sergent, G., Lebuffe, G., Gambiez, L., Ernst, O., et al. Remnant liver volume to body weight ratio > or =0.5%: a new cut-off to estimate postoperative risks after extended resection in noncirrhotic liver. J Am Coll Surg 204 (2007), 22–33.
4. 4 Vauthey, J.N., Abdalla, E.K., Doherty, D.A., Gertsch, P., Fenstermacher, M.J., Loyer, E.M., et al. Body surface area and body weight predict total liver volume in Western adults. Liver Transpl 8 (2002), 233–240.
5. 5 Erdogan, D., Heijnen, B.H., Bennink, R.J., Kok, M., Dinant, S., Straatsburg, I.H., et al. Preoperative assessment of liver function: a comparison of 99mTc-Mebrofenin scintigraphy with indocyanine green clearance test. Liver Int 24 (2004), 117–123.
6. 6 de Graaf, W., van Lienden, K.P., van Gulik, T.M., Bennink, R.J., (99m)Tc-mebrofenin hepatobiliary scintigraphy with SPECT for the assessment of hepatic function and liver functional volume before partial hepatectomy. J Nucl Med 51 (2010), 229–236.
7. 7 de Graaf, W., van Lienden, K.P., Dinant, S., Roelofs, J.J., Busch, O.R., Gouma, D.J., et al. Assessment of future remnant liver function using hepatobiliary scintigraphy in patients undergoing major liver resection. J Gastrointest Surg 14 (2010), 369–378.
8. 8 Ekman, M., Fjalling, M., Friman, S., Carlson, S., Volkmann, R., Liver uptake function measured by IODIDA clearance rate in liver transplant patients and healthy volunteers. Nucl Med Commun 17 (1996), 235–242.
9. 9 Bennink, R.J., Dinant, S., Erdogan, D., Heijnen, B.H., Straatsburg, I.H., van Vliet, A.K., et al. Preoperative assessment of postoperative remnant liver function using hepatobiliary scintigraphy. J Nucl Med 45 (2004), 965–971.
10. 10 Clavien, P.A., Barkun, J., de Oliveira, M.L., Vauthey, J.N., Dindo, D., Schulick, R.D., et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 250 (2009), 187–196.
11. 11 Rahbari, N.N., Garden, O.J., Padbury, R., Brooke-Smith, M., Crawford, M., Adam, R., et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 149 (2011), 713–724.
12. 12 Bennink, R.J., Tulchinsky, M., de Graaf, W., Kadry, Z., van Gulik, T.M., Liver function testing with nuclear medicine techniques is coming of age. Semin Nucl Med 42 (2012), 124–137.
13. 13 Dinant, S., de Graaf, W., Verwer, B.J., Bennink, R.J., van Lienden, K.P., Gouma, D.J., et al. Risk assessment of posthepatectomy liver failure using hepatobiliary scintigraphy and CT volumetry. J Nucl Med 48 (2007), 685–692.
14. 14 Farges, O., Regimbeau, J.M., Fuks, D., Le Treut, Y.P., Cherqui, D., Bachellier, P., et al. Multicentre European study of preoperative biliary drainage for hilar cholangiocarcinoma. Br J Surg 100 (2013), 274–283.
15. 15 van Gulik, T.M., Ruys, A.T., Busch, O.R., Rauws, E.A., Gouma, D.J., Extent of liver resection for hilar cholangiocarcinoma (Klatskin tumor): how much is enough?. Dig Surg 28 (2011), 141–147.
16. 16 Truant, S., Boleslawski, E., Sergent, G., Leteurtre, E., Duhamel, A., Hebbar, M., et al. Liver function following extended hepatectomy can be accurately predicted using remnant liver volume to body weight ratio. World J Surg 39 (2015), 1193–1201.